| Date Filed | Type | Description |
| 08/11/2023 |
4
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Disposed/sold 3,300 shares
@ $0
Disposed/sold 23,522 options to buy
@ $14.77, valued at
$347.4k
Disposed/sold 5,948 options to buy
@ $16.81, valued at
$100k
Disposed/sold 13,300 options to buy
@ $13.88, valued at
$184.6k
|
|
| 05/31/2023 |
4
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Exercised 3,300 restricted stock units
@ $0 |
|
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2023 |
4
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.67, valued at
$33.4k
|
|
| 03/08/2023 |
4
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 14,775 shares
@ $0
Granted 23,329 options to buy
@ $8.46, valued at
$197.4k
|
|
| 09/15/2022 |
4
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 4,000 options to buy
@ $0.86, valued at
$3.4k
|
|
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2022 |
4
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on Acer Therapeutics Inc.|
Txns:
| Granted 18,500 options to buy
@ $2.21, valued at
$40.9k
|
|
| 08/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2021 |
4
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 4,000 options to buy
@ $6.25, valued at
$25k
|
|
| 07/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 4,000 shares
@ $40, valued at
$160k
Exercised 4,000 options to buy
@ $7.8, valued at
$31.2k
|
|
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2021 |
4
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 2,500 shares
@ $35, valued at
$87.5k
Exercised 2,500 options to buy
@ $7.8, valued at
$19.5k
|
|
| 04/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2020 |
4
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 982 shares
@ $57.42, valued at
$56.4k
Sold 3,367 shares
@ $58.96, valued at
$198.5k
Sold 1,651 shares
@ $59.44, valued at
$98.1k
Exercised 6,000 options to buy
@ $7.8, valued at
$46.8k
|
|
| 11/18/2020 |
4
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Sold 5,021 shares
@ $47.57, valued at
$238.8k
Sold 979 shares
@ $48.3, valued at
$47.3k
Exercised 6,000 options to buy
@ $7.8, valued at
$46.8k
|
|
| 10/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/21/2020 |
4
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 60,000 options to buy
@ $0.46, valued at
$27.6k
|
|
| 02/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2019 |
4
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 2,500 shares
@ $0
Granted 10,000 options to buy
@ $1.04, valued at
$10.4k
|
|
| 06/26/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2018 |
4
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 20,000 options to buy
@ $3.31, valued at
$66.2k
|
|
| 08/17/2018 |
3
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 3 on HTG MOLECULAR DIAGNOSTICS, INC |
|